A Clinical Study to Assess the Safety and Effectiveness of Test Products in Healthy Adult Human Subjects With Dry and Sensitive Skin.

NACompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

December 7, 2024

Primary Completion Date

February 18, 2025

Study Completion Date

February 18, 2025

Conditions
Dry and Sensitive Skin
Interventions
OTHER

Moiz MM

"Mode of Usage: After cleansing, apply liberally onto the skin and gently massage until fully absorbed.~Manufactured By: Dermalogics Marketed By: Glowderma Lab Private Limited Frequency: Twice a Day Route of Administration: Topical"

OTHER

Moiz XL

"Mode of Usage: After cleansing, apply liberally onto the skin and gently massage until fully absorbed.~Manufactured By: Dermalogics Marketed By: Glowderma Lab Private Limited Frequency: Twice a Day Route of Administration: Topical"

OTHER

Moiz LMF 48

"Mode of Usage: After cleansing, apply liberally onto the skin and gently massage until fully absorbed.~Manufactured By: Dermalogics Marketed By: Glowderma Lab Private Limited Frequency: Twice a Day or as often as needed Route of Administration: Topical"

Trial Locations (1)

382481

NovoBliss Research Pvt.Ltd, Ahmedabad

All Listed Sponsors
collaborator

Glowderma Lab Private Limited

UNKNOWN

lead

NovoBliss Research Pvt Ltd

OTHER

NCT06678464 - A Clinical Study to Assess the Safety and Effectiveness of Test Products in Healthy Adult Human Subjects With Dry and Sensitive Skin. | Biotech Hunter | Biotech Hunter